نتایج جستجو برای: suberoylanilide hydroxamic acid saha

تعداد نتایج: 748959  

Journal: :International journal of oncology 2014
Fei-Ting Hsu Yu-Chang Liu I-Tsang Chiang Ren-Shyan Liu Hsin-Ell Wang Wuu-Jyh Lin Jeng-Jong Hwang

Sorafenib is effective for patients with advanced hepatocellular carcinoma (HCC) and particularly for those who are unsuitable to receive life-prolonging transarterial chemo-embolization. The survival benefit of sorafenib, however, is unsatisfactory. Vorinostat also known as suberoylanilide hydroxamic acid (SAHA) is a histone deacetylase (HDAC) inhibitor with anti-HCC efficacy in preclinical st...

2012
Markus Thiemann Susanne Oertel Volker Ehemann Wilko Weichert Albrecht Stenzinger Marc Bischof Klaus-J Weber Ramon Lopez Perez Uwe Haberkorn Andreas E Kulozik Jürgen Debus Peter E Huber Claudia Battmann

PURPOSE Histone deacetylase inhibitors are promising new substances in cancer therapy and have also been shown to sensitize different tumor cells to irradiation (XRT). We explored the effect as well as the radiosensitizing properties of suberoylanilide hydroxamic acid (SAHA) in vivo in a malignant rhabdoid tumor (MRT) mouse model. METHODS AND MATERIAL Potential radiosensitization by SAHA was ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Nichole Boyer Arnold Nohea Arkus Jason Gunn Murray Korc

PURPOSE Pancreatic cancer is an aggressive human malignancy that is generally refractory to chemotherapy. Histone deacetylase inhibitors are novel agents that modulate cell growth and survival. In this study, we sought to determine whether a relatively new histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), inhibits pancreatic cancer cell growth. EXPERIMENTAL DESIGN The eff...

Journal: :Nucleic acids research 2001
D Benjamin J P Jost

We have constructed a stable cell line, human embryonal kidney 293M+, containing a lacZ reporter gene controlled by an in vitro methylated hormone-responsive enhancer. Methylation of the enhancer-promoter abolishes lacZ expression controlled by ponasterone A (an analogue of ecdysone). Ponasterone A-induced expression is restored by the short-chain fatty acids valeric > butyric > propionic > ace...

Journal: :Blood 2003
Ramadevi Nimmanapalli Lianne Fuino Corinne Stobaugh Victoria Richon Kapil Bhalla

Here we demonstrate that treatment with SAHA (suberoylanilide hydroxamic acid), a known inhibitor of histone deacetylases (HDACs), alone induced p21 and/or p27 expressions but decreased the mRNA and protein levels of Bcr-Abl, which was associated with apoptosis of Bcr-Abl-expressing K562 and LAMA-84 cells. Cotreatment with SAHA and imatinib (Gleevec) caused more down-regulation of the levels an...

Journal: :Cancer research 2001
P N Munster T Troso-Sandoval N Rosen R Rifkind P A Marks V M Richon

Histone deacetylase (HDACs) regulate histone acetylation by catalyzing the removal of acetyl groups on the NH(2)-terminal lysine residues of the core nucleosomal histones. Modulation of the acetylation status of core histones is involved in the regulation of the transcriptional activity of certain genes. HDAC activity is generally associated with transcriptional repression. Aberrant recruitment...

2010
L. K. TIWARY

Hydroxamic acids serve as a monsulfhydril bisubstrate analog inhibition of fernesyl protein transferase (FPT), the enzyme catalysing fernesylation of p21ras. Tumor necrosis factor (TFN) is specifically prevented by synthetic hydroxamic acid-based metalloproteinase inhibitors. Suberoyanilide hydroxamic acid (SAHA) have been identified as histone deacetylase inhibitors based on their ability to i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید